PLGA nanoparticle-integrated microneedles for controlled transdermal delivery of ADT-OH to ameliorate endothelial dysfunction in vitro

Abstract

Endothelial dysfunction, a central feature of vascular diseases such as diabetes and atherosclerosis, is associated with oxidative stress and inflammation. Hydrogen sulphide-donors such as ADT-OH provide vascular protection but suffer from rapid clearance and poor bioavailability. To address this, we developed a dual-polymer delivery system that integrates biodegradable poly(lactic-co-glycolic acid) (PLGA) nanoparticles within poly(vinyl alcohol) microneedles to achieve sustained transdermal release of ADT-OH.   Microneedle arrays were fabricated from poly(vinyl alcohol) and trehalose, incorporating free ADT-OH or ADT-OH–loaded PLGA nanoparticles. Mechanical strength and insertion capacity of polymeric microneedles were characterised, followed by ex-vivo Franz diffusion studies in murine skin. The polymer system was further evaluated for its ability to preserve drug activity in a HUVEC model of endothelial dysfunction. Nanoparticles were successfully prepared and characterised by STEM imaging and HPLC-UV, confirming efficient encapsulation. Incorporation into dissolving microneedles did not compromise their structural integrity or penetration efficiency. Compared with unencapsulated drug, nanoparticle-loaded ADT-OH observed sustained release (56.3 ± 7.4% vs. 40.2 ± 7.2% in 24h). In endothelial dysfunction models, TNF-α stimulation elevated IL-6 secretion (80.63 ± 9.90pg/mL), which was suppressed by permeated ADT-OH (48.17 ± 9.64pg/mL, p<0.0001). Treatment significantly reduced intracellular ROS and preserved mitochondrial function. Permeated ADT-OH retained pro-angiogenic activity, significantly enhancing HUVEC tube formation (p≤0.01). This study demonstrates that integrating poly(vinyl alcohol) microneedles with PLGA nanoparticles provides a polymer-based platform for minimally invasive, sustained delivery of hydrogen sulphide-donors. The system preserved anti-inflammatory, antioxidant, and pro-angiogenic activities of ADT-OH, underscoring its potential to restore endothelial function.

Publication DOI: https://doi.org/10.1016/j.ijpharm.2025.126535
Divisions: College of Health & Life Sciences > Aston Medical School
College of Health & Life Sciences
College of Engineering & Physical Sciences > School of Engineering and Technology > Mechanical, Biomedical & Design
College of Engineering & Physical Sciences > Engineering for Health
College of Engineering & Physical Sciences > Aston Institute of Materials Research (AIMR)
College of Engineering & Physical Sciences
College of Health & Life Sciences > Aston Medical School > Translational Medicine Research Group (TMRG)
College of Health & Life Sciences > School of Biosciences > Cellular and Molecular Biomedicine
College of Health & Life Sciences > Aston Pharmacy School
Aston University (General)
Additional Information: Crown Copyright © 2025 Published by Elsevier B.V. This is an open access article under the CC BY license (https://creativecommons.org/licenses/by/4.0/).
Uncontrolled Keywords: Drug delivery,Nanoparticles,Controlled drug release,Hydrogen sulphide donors
Publication ISSN: 1873-3476
Last Modified: 06 Jan 2026 08:16
Date Deposited: 05 Jan 2026 16:13
Full Text Link:
Related URLs: https://linking ... 378517325013729 (Publisher URL)
PURE Output Type: Article
Published Date: 2026-02-10
Published Online Date: 2025-12-24
Accepted Date: 2025-12-23
Authors: Marwah, Mandeep Kaur (ORCID Profile 0000-0003-4881-003X)
Balakrishnan, Pavanjeeth
Junaid, Sarah (ORCID Profile 0000-0001-9460-710X)
Ahmad, Shakil (ORCID Profile 0000-0002-9294-0475)
Shokr, Hala
Upadhya, Manoj (ORCID Profile 0000-0002-2032-1472)
Sanchez-Aranguren, Lissette (ORCID Profile 0000-0002-4663-5752)

Download

[img]

Version: Published Version

License: Creative Commons Attribution


Export / Share Citation


Statistics

Additional statistics for this record